Whether decellularization and recellularization will have medical use in the future is up for grabs. What’s clear, though, is that you can play around with this cutting-edge biotech right now ...

Decellularization as a Urethral Stricture Treatment Decellularization is a promising approach to treating urethral strictures, offering potential advantages over traditional methods. In this process, ...

Whole organ decellularization is achieved through perfusion, which delivers the decellularizing agents (detergents and enzymes) using the tissue’s own vasculature. Obviously, this is a complex process ...

Decellularization is the process of removing all of the cells from an organ -- in this case an animal cadaver heart -- leaving only the extracellular matrix, the framework between the cells, intact.

Over a period of 52 hours, infusion of a detergent solution removes cells from a rat forelimb, leaving behind the cell-free matrix scaffolding onto which new tissues can be regenerated. For more ...

Miromatrix's perfusion decellularization and recellularization technology platform includes 119 issued and 34 pending patent applications, with protection in the United States and major markets ...

Tissue Regenix was founded in the U.K. in 2006 to develop and commercialize decellularization research from the University of Leeds and listed on the London Stock Exchange in 2010.

Decellularization, on the other hand, can substantially reduce the mechanical properties and structural stability of all dECM sheets. In this study, over 300 original research papers covering ...